In patients with cirrhosis, serum albumin determination should be carried out by immunonephelometry rather than by protein electrophoresis

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 12, 1999, Pages 1405-1411

  Mendler, Michel Henry ^a   Corbinais, Stéphane ^a   Sapey, Thierry ^a   Lucas Clerc, Catherine ^a   Tiisma, Virge ^a   Guyader, Dominique ^a   Deugnier, Yves ^a   Treut, André Le ^a   Brissot, Pierre ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Child Pugh classification; Cirrhosis; Immunonephelometry; Protein electrophoresis; Serum albumin

Indexed keywords

BIURET; SERUM ALBUMIN;

ADULT; AGED; ALCOHOLISM; ARTICLE; CLASSIFICATION; CLINICAL TRIAL; DEVICE; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; NEPHELOMETRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN ELECTROPHORESIS;

EID: 0033455584     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199912000-00011     Document Type: Article

References (53)

1. 1 Blakemore AH. Portacaval shunting for portal hypertension. Surg Gynecol Obstet 1952; 94:443-454.
2. 2 Child CGI, Turcotte JG. Surgery and hypertension. In: The Liver and Portal Hypertension. Child CGI, Turcotte JG (editors). Philadelphia: WB Saunders; 1964. pp. 1-85.
3. 3 Campbell DP, Parker DE, Anagnostopoulos CE. Survival prediction in portocaval shunts: a computerized statistical analysis. Am J Surg 1973; 126:748-751.
4. 4 Pugh NH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-648.
5. 5 Conn HO. A peek at the Child-Turcotte classification. Hepatology 1981; 1:673-676.
6. 6 Conn HO, Resnick RH, Grace ND, et al. Distal splenorenal shunt vs. portal-systemic shunt: current status of a controlled trial. Hepatology 1981; 1:151-160.
7. 7 Schlichting P, Christensen E, Andersen PK, et al. Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology 1983; 3:889-895.
8. 8 Christensen E, Schlichting P, Fauerholdt L, et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1984; 4:430-435.
9. 9 Christensen E, Schlichting P, Fauerholdt L, et al. Changes of laboratory variables with time in cirrhosis: prognostic and therapeutic significance. Hepatology 1985; 5:843-853.
10. 10 Christensen E, Schlichting P, Andersen PK, et al. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 1986; 21:163-174.
11. 11 Infante-Rivard C, Esnaola S, Villeneuve J-P. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987; 7:660-664.
12. 12 Oellerich M, Burdelski M, Lautz H-U, et al. Assessment of pretransplant prognosis in patients with cirrhosis. Transplantation 1991; 51:801-806.
13. 13 Zoli M, Cordiani MR, Marchesini G, et al. Prognostic indicators in compensated cirrhosis. Am J Gastroenterol 1991; 86:1508-1513.
14. 14 Pasqualetti P, Di Lauro G, Festuccia V, Giandomenico G, Casale R. Prognostic value of Pugh's modification of Child-Turcotte classification in patients with cirrhosis of the liver. Panminerva Med 1992; 34:65-68.
15. 15 Salerno F, Borroni G, Moser P, et al. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 1993; 88:514-519.
16. 16 Christensen E, Altman DG, Neuberger J, et al. Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. Gastroenterology 1993; 105:1865-1876.
17. 17 Zimmerer J, Haubitz I, Mainos D, Hadass H, Tittor W. Survival in alcoholic liver cirrhosis: prognostic value of portal pressure, size of esophageal varices and biochemical data. Comparison with Child classification. Z Gastroenterol 1996; 34:421-427.
18. 18 Rodeck B, Welter M, Kardorff R, et al. Liver transplantation in children with chronic end stage liver disease. Transplantation 1996; 62:1071-1076.
19. 19 Salerno F, Borroni G, Moser P, et al. Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. J Hepatol 1996; 25:474-480.
20. 20 Ricci P, Therneau TM, Malinchoc M, et al. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology 1997; 25:672-677.
21. 21 Adler M, Verset D, Bouhdid H, et al. Prognostic evaluation of patients with parenchymal cirrhosis, proposal of a new simple score. J Hepatol 1997; 26:642-649.
22. 22 Ballmer PE, Walshe D, McNurlan MA, Watson H, Brunt PW, Garlick PJ. Albumin synthesis rates in cirrhosis: correlation with Child-Turcotte Classification. Hepatology 1993; 18:292-297.
23. 23 Ballmer PE, Reichen J, McNurlan MA, Sterchi A-B, Anderson SE, Garlick PJ. Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver. Hepatology 1996; 24:53-59.
24. 24 Trey C, Burns DG, Saunders SJ. Treatment of hepatic coma by exchange blood transfusion. N Engl J Med 1966; 274:473-481.
25. 25 Teasdale G, Jennett B. Assessment of coma and impaired consciousness. Lancet 974; ii:81-84.
26. 26 Conn H, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72:573-583.
27. 27 Conn H, Lieberthal MM. The Hepatic Syndromes and Lactulose. Baltimore: Williams & Wilkins; 1979.
28. 28 Bijster P, Vader HL, Vink CL. On the standardisation of the direct spectrophotometric bilirubin determination. Influence of the albumin source and the molar bilirubin:albumin ratio. Ann Clin Biochem 1981; 18:102-105.
29. 29 Perry BW, Doumas BT, Bayse DD, et al. A candidate reference method for determination of bilirubin in serum. Test for transferability. Clin Chem 1983; 29:297-301.
30. 30 Ryan FJ, Mathies JC. A total and direct bilirubin determination using an SDS procedure on the Abott Bichromatic Analyser. Clin Biochem 1983; 16:254-258.
31. 31 Kosaka A, Yamamoto C, Morishita Y, Nakane K. Enzymatic determination of bilirubin fractions in serum. Clin Biochem 1987; 20:451-458.
32. 32 Heinemann G, Vogt W. The determination of bilirubin with a new enzymatic method (Dri-STAT bilirubin) using the Hitachi 704 selective analyzer. J Clin Chem Clin Biochem 1988; 26:391-397.
33. 33 Becker DM, Humpheries JE, Walker FBt, DeMong LK, Bopp JS, Acker MN. Standardizing the prothrombin time. Calibrating coagulation instruments as well as thromboplastin. Arch Pathol Lab Med 1993; 117:602-605.
34. 34 Braun PJ, Szewczyk KM. Relationship between total prothrombin, native prothrombin and the International Normalized Ratio (INR). Thromb Haemost 1992; 68:160-164.
35. 35 Bussey HI, Force RW, Bianco TM, Leonard AD. Reliance on prothrombin time ratios causes significant errors in anticoagulation therapy. Arch Intern Med 1992; 152:278-282.
36. 36 Gouin I, Horellou MH, Conard J, Samama M. Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients. Arch Mal Coeur Vaiss 1990; 83:357-361.
37. 37 Sansores-Garcia L, Majluf-Cruz AS, Vargas-Vorackova F, Lanardini-Méndez J. The international normalization ratio in the monitoring of oral coagulant therapy. Rev Invest Clin 1993; 45:463-467.
38. 38 Shulman G. The value of quantitative protein electrophoresis. S Afr Med J 1976; 50:2059-2063.
39. 39 Zuberi SJ, Lodi TZ. Serum protein electrophoresis in healthy subjects and patients with liver disease. J Pakistan Med Assoc 1978; 28:140-141.
40. 40 Griffiths BW, Sparkes BG, Greenberg L. The quantitation of human albumin by immunoelectrophoresis. Can J Biochem 1965; 43:1915-1917.
41. 41 Hobbs JR. Standardisation in relation to human albumin. La Ricerca Clin Lab 1980; 10:173-178.
42. 42 Tarnoky AL. Albumin. Ann Clin Biochem 1981; 18:61-63.
43. 43 Shulman G. Comparison of specific protein assays in biological fluids by radial immunodiffusion and laser nephelometer. Clin Biochem 1979; 12:123-125.
44. 44 Shulman G, Paul EM. Cost containment in laser immunonephelometry. Clin Biochem 1980; 13:171-176.
45. 45 Bruver RM, Salkie ML. A comparative study of three approaches to the routine quantitation of human serum proteins. Clin Biochem 1978; 11:112-116.
46. 46 Keyser JW, Fifield R, Watkins GL. Standardisation of immunochemical determinations of serum albumin. Clin Chem 1981; 27:736-738.
47. 47 Besozzi M, Chelazzi G, Franzini C, Maggiore M. Kinetic-immunonephelometric determination of serum proteins in chronic liver diseases. Quad Sclavo Diagn 1982; 18:308-315.
48. 48 Jenhani F, Ayed K, Jedidi S, Ben Khelifa F, Ben Ayed H. Comparaison de trois techniques de dosage de la microalbuminurie chez les diabétiques insulo-dépendants: radioimmunologie, néphélémétrie-laser et électro-immuno-diffusion de Laurell. Diabete Metab 1990; 16:98-101.
49. 49 Massoubre C, Orsonneau JL, Massourbre B, Blanchardie P, Lustenberger P. Micro-albuminurie: évaluation d'une méthode immunoturbidimétrique et d'une méthode immunonéphélémétrique. Ann Biol Clin 1989; 47:391-395.
50. 50 Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949; 177:751-766.
51. 51 Naudin C, Boval-Gallet C, Reault S, Rosa F, Blanch C. Evaluation du système Hydrasis-Hyrys. Revue Française des Laboratoires 1996; 285:87-90.
52. 52 Veering BTH, Burm AGL, Souverijn JHM, Serree JMP, Spierdijk JOH. The effect of age on serum concentrations of albumin and alpha 1-acid glycoprotein. Br J Clin Pharmacol 1990; 29:201-206.
53. 53 Mabuchi H, Nakahashi H. Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremia. Clin Chil Acta 1987; 167:89-96.